Understanding the effect of phosphodiesterase 4D in regulating cardiac responsiveness to dobutamine may provide the potential of a PDE4D targeted therapy for sepsis patients with low cardiac output requiring inotropic support in future. The gene discussed is PDE4D; the disease is Sepsis.